Royal Bank of Canada
MAIA icon

Royal Bank of Canada’s MAIA Biotechnology MAIA Stock Holding History

Royal Bank of Canada’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-268
Closed – – 7614
2026
Q1 		$0 Buy
+268
New +$494 ﹤0.01% 7447
2025
Q1 		– Sell
-3,000
Closed -$6K – 7065
2024
Q4 		$6K Buy
+3,000
New +$7.19K ﹤0.01% 6498
2024
Q3 		– Sell
-86
Closed – – 7182
2024
Q2 		$0 Buy
86
+58
+207% +$183 ﹤0.01% 7339
2024
Q1 		$0 Sell
28
-120
-81% -$180 ﹤0.01% 7343
2023
Q4 		$0 Buy
148
+121
+448% +$195 ﹤0.01% 7384
2023
Q3 		$0 Hold
27
– – ﹤0.01% 7357
2023
Q2 		$0 Buy
+27
New +$72 ﹤0.01% 7480
2022
Q4 		– Sell
-22
Closed – – 7512
2022
Q3 		$0 Buy
+22
New +$93 ﹤0.01% 7671

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $643M AUM 21% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada's MAIA Position: Q2 2026 in Review

Royal Bank of Canada sold out of MAIA Biotechnology (MAIA) in Q2 2026, closing a stake of 268 shares.

Royal Bank of Canada first reported a position in MAIA in Q3 2022 and held it in 8 quarters. The position peaked at $6K in Q4 2024. 36 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

  • Royal Bank of Canada reported no remaining MAIA Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 268 MAIA Biotechnology shares in Q2 2026.
  • Royal Bank of Canada first reported a position in MAIA Biotechnology in Q3 2022 and held it in 8 quarters.
  • Royal Bank of Canada's MAIA Biotechnology position peaked at $6K in Q4 2024.
  • 36 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.